Jina Sawani
Communications Manager

Sawani serves as the communications manager at Michigan Medicine with responsibility for community benefits and environmental, social and governance, or ESG, priorities, as well as pharmacy and innovation, government relations and select integration work that crosses all units. Previously, she was a part of the public relations team for several years, where she handled media relations and written communication for various departments across the institution. Sawani is passionate about fostering a sense of unity and bridging gaps between cultures through the art of storytelling. Prior to joining U-M in 2017, she worked in public affairs and government communications in Washington, D.C., and Southeastern Michigan. Contact: [email protected].

Jina Sawani
See through body of end stage kidney disease with teal blue background
Health Lab
Does Bariatric Surgery Help or Harm Patients with ESKD?
Research shows bariatric surgery is not only safe for patients with end-stage kidney disease (ESKD), but may aid in their ability to qualify for a kidney transplant.
Luke clinic patients and doctors
Health Lab
Bringing Prenatal and Infant Care to Underserved Communities
The Luke Clinic provides free prenatal, postpartum and infant care (through one year of life) to any family in the Detroit metro area.
Transgender COVID
Health Lab
Lifting Barriers to Care for Transgender and Non-Binary Patients
Providing gender-affirming care to the transgender and non-binary community is essential. During the COVID-19 pandemic, barriers have been lifted to continue to provide this care virtually.
Person taking temperature
Health Lab
Racial Disparities in the Time of COVID-19
Black Americans have experienced a vastly disproportionate death rate during the COVID-19 pandemic, acutely magnifying the racial disparities and health inequities that affect communities of color.
Woman bent over holding chest in light blue sweater.
Health Lab
Physician Perceptions On PPIs
A new study reveals that providers may be recommending patients stop the use of PPI’s in some cases where the benefits would likely outweigh potential side effects.
Health Lab
Ranitidine Recall: Alternative Treatments for Heartburn
Dr. William Chey, gastroenterologist, discusses the treatment of heartburn now that ranitidine (Zantac) has been recalled by the FDA.
Women in stomach pain
Health Lab
Are Digestive Issues a Symptom of COVID-19?
New studies out of Wuhan, China are showing that diarrhea can be an unrecognized, early symptom of COVID-19, sometimes presenting ahead of respiratory symptoms.
News Release
Senior medical students reveal their residency destinations
Today, 173 University of Michigan medical students excitedly learned their fates as future health care providers as they read their letter from the National Residency Match Program, revealing where they’ll head for the next chapter of their training. But this time, it happened electronically.
News Release
Medical School, School of Nursing strong in 2021 Best Graduate School rankings
Michigan Medicine continues to excel in training the next generation of health care leaders, as reflected in the 2021 U.S. News and World Report Best Graduate School rankings, released today (March 17).
Coronavirus scanning lungs
Health Lab
How Does COVID-19 Appear in the Lungs?
COVID-19 can clinically manifest similarly to other respiratory illnesses and can also appear similar on imaging scans. Two radiologists have teamed up and found imaging anomalies that can serve as an alert to radiologists that COVID-19 may be present in
Health Lab
The Brain-Gut Connection: A Path to Wellness Through GI Hypnosis
The gut-brain axis illustrates the reciprocal nature of our physical health affecting our mental health, and vice versa. Through GI hypnosis, one Michigan Medicine doctor is helping patients navigate the gut-brain connection.
Photo with person and cannabis leaf
Health Lab
Cannabis for Treating IBD: Hope or Hype?
For patients with IBD, medical marijuana may be used as a potential therapy to manage symptoms, but it may not work for everyone. A gastroenterologist breaks down what we know so far from studies.
Person going into MRI looking from inside
Health Lab
Are Group II GBCAs Safe for Patients with Chronic Kidney Disease?
Researchers at Michigan Medicine find that the per patient risk of using group II GBCA in patients with chronic kidney disease (CKD) appears to be less than 1%, though larger studies are still needed.
Patient in hospital bed
Health Lab
A Voice of Hope: One Patient’s Journey to Speak Again After House Fire
Michigan Medicine Otolaryngologist Dr. Norman Hogikyan helped 22-year-old Madison Marciniak breathe easy again after surviving a house fire.
Health Lab
New Study has Global Impact on Hepatitis C Elimination Efforts
Michigan Medicine researchers have advanced the global fight to eliminate hepatitis C by creating a barrier-breaking reliable, low-cost and scalable test for HCV.
  • 8
  • 9
  • 10